Showing results (101-110 of 126) with videos related to

Sort By:
Pageof 13
Plos One|September 17, 2025
Blockade of interleukin-6 (IL-6) signaling in dedifferentiated liposarcoma (DDLPS) decreases mouse double minute 2 (MDM2) oncogenicity via alternative splicingAbeba Zewdu, Danielle Braggio, Gonzalo Lopez, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 4, 2018
SAMHD1 suppresses innate immune responses to viral infections and inflammatory stimuli by inhibiting the NF-κB and interferon pathwaysShuliang Chen, Serena Bonifati, Zhihua Qin, et al.
Molecular Cancer Therapeutics|January 25, 2023
Redundant Signaling as the Predominant Mechanism for Resistance to Antibodies Targeting the Type-I Insulin-Like Growth Factor Receptor in Cells Derived from Childhood SarcomaTerry J Shackleford, Seethalakshmi Hariharan, Angelina V Vaseva, et al.
Cancer Discovery|June 30, 2016
Dissection of the Major Hematopoietic Quantitative Trait Locus in Chromosome 6q23.3 Identifies miR-3662 as a Player in Hematopoiesis and Acute Myeloid LeukemiaSophia E Maharry, Christopher J Walker, Sandya Liyanarachchi, et al.
The Journal of Clinical Investigation|October 3, 2013
NF-κB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexiaWei A He, Emanuele Berardi, Veronica M Cardillo, et al.
Cell Reports|March 31, 2023
Targeting protein tyrosine phosphatases for CDK6-induced immunotherapy resistanceXueliang Gao, Yongxia Wu, Joel M Chick, et al.
Journal of Cachexia, Sarcopenia and Muscle|January 10, 2018
Circulating monocyte chemoattractant protein-1 (MCP-1) is associated with cachexia in treatment-naïve pancreatic cancer patientsErin E Talbert, Heather L Lewis, Matthew R Farren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2025
Randomized Phase II Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab as First-Line Treatment in Advanced Pancreatic Cancer: Survival and CachexiaInna M Chen, Julia S Johansen, Susann Theile, et al.
Plos One|January 3, 2018
MiR-34a regulates the invasive capacity of canine osteosarcoma cell linesCecilia M Lopez, Peter Y Yu, Xiaoli Zhang, et al.
The Journal of Clinical Investigation|March 24, 2007
Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophySwarnali Acharyya, S Armando Villalta, Nadine Bakkar, et al.
Pageof 13